American Breast Laser Ablation Therapy Evaluation (ABLATE): Monitoring the long term safety and efficacy of Novilase breast interstitial laser therapy in real world application
An observational study for women undergoing breast surgery using a laser therapy called Novilase
Sponsor: Novian Health Inc.
Enrolling: Female Patients Only
IRB Number: AAAM8510
U.S. Govt. ID: NCT00807924
Contact: Bret Taback, MD: 212-342-3681 /
Additional Study Information: The purpose of this study is to capture and evaluate clinical data about the long-term safety and effectiveness of Novilasee - a FDA-cleared minimally invasive treatment for benign breast tumors in hopes that tracking and analyzing the safety and effectiveness of Novilase in a real world application will benefit future patients and the breast cancer community. Furthermore, information collected could be used to develop new and improved breast cancer treatment techniques.
This study is closed
Bret Taback, MD
Do You Qualify?
Have tumors been detected either by physical exam or imaging? Yes No
Are you pregnant or lactating? Yes No
You may be eligible for this study

Place Holder

For more information, please contact:
Bret Taback, MD